featured
Outcomes of Treatment With Baricitinib in Patients With Moderate to Severe Alopecia Areata Aged 65 Years or Older
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical and Experimental Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Treatment of moderate-to-severe alopecia areata in patients over the age of 65 with baricitinib
Clin Exp Dermatol 2024 Jan 25;[EPub Ahead of Print], GT Tang, D Triwongwaranat, R Sinclair, S Joseph, S Eisman, D Rathnayake, V Varathan, L Trindade de Carvalho, B BhoyrulFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.